Leyden Labs
Develops nasal spray-based respiratory virus prevention products, with a current focus on addressing influenza protection beyond traditional vaccines.
Overview
Leyden Labs is a biotechnology company developing a nasal spray approach aimed at preventing respiratory infections, with its current public funding narrative centered on influenza. The company is positioned around a non-traditional prophylactic format that could complement or challenge decades of flu vaccine development. Its target market is respiratory disease prevention, including public health use cases where broader or easier-to-administer protection is valuable. Leyden Labs raised €40M in a round backed by the Gates Foundation, highlighting philanthropic interest in alternatives to existing flu-prevention tools.
Funding History
Gates Foundation backs Leyden Labs’ €40M raise: Can a nasal spray do what 80 years of flu vaccines couldn’t
Frequently Asked Questions
- How much has Leyden Labs raised in total?
- Leyden Labs has raised a total of $40M across 1 funding round.
- Who are Leyden Labs's investors?
- Leyden Labs's investors include Undisclosed.
- What does Leyden Labs do?
- Leyden Labs is a biotechnology company developing a nasal spray approach aimed at preventing respiratory infections, with its current public funding narrative centered on influenza. The company is positioned around a non-traditional prophylactic format that could complement or challenge decades of flu vaccine development. Its target market is respiratory disease prevention, including public health use cases where broader or easier-to-administer protection is valuable. Leyden Labs raised €40M in a round backed by the Gates Foundation, highlighting philanthropic interest in alternatives to existing flu-prevention tools.
- Where is Leyden Labs headquartered?
- Leyden Labs is headquartered in Amsterdam, Netherlands.
Investors
Related Insights
A comprehensive analysis of Isembard's funding history, investors, competitive position, and growth trajectory in the Deep Tech space.
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
Every AI funding round in June 2026—from Lovable's $12B raise to top fintech, infrastructure & enterprise deals. Updated daily with VCs, valuations & trends.